Further implications from a pragmatic randomized clinical trial of gestational diabetes screening: per-protocol and as-treated estimates - 29/10/21

Plan
| The authors report no conflict of interest. |
|
| This work was supported by grant number R01HD074794 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (awarded to T.A.H.). Neither the funder nor the authors’ institutions had any role in the study design; collection, analysis or interpretation of the data; writing of the report; or decision to submit the article for publication. |
|
| The ScreenR2GDM clinical trial is registered with ClinicalTrials.gov (ClinicalTrials.gov identifier: NCT02266758). Initial trial registration was on May 22, 2014, and the first patient was enrolled on June 3, 2014. |
Vol 225 - N° 5
P. 581-583 - novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
